American Journal of Respiratory and Critical Care Medicine · 2009 · 152 citations · 13 references
MedicineCardiologyExercise TestingPulmonary Function TestingPulmonologyCardiopulmonary Exercise TestingExercise Pulmonary Function TestingExercise Tolerance AssessmentPulmonary HypertensionPulmonary Vascular DiseaseSystemic Sclerosis6-Minute Walk TestLung FibrosisPulmonary Arterial PressurePulmonary HemodynamicsPulmonary Hypertension In SclerodermaPulmonary Vascular Resistance AssessmentPulmonary Vascular Resistance EstimationVascular Resistance
RATIONALE: Pulmonary arterial hypertension is associated with impaired exercise capacity and decreased survival in patients with scleroderma. Randomized controlled studies showed significant benefit of targeted therapies in patients with a resting mean pulmonary arterial pressure (MPAP) greater than 25 mm Hg. The clinical relevance of pulmonary arterial pressure values in the upper normal range is unknown. OBJECTIVES: To examine the clinical relevance of pulmonary arterial pressure in scleroderma patients. METHODS: After a noninvasive screening program, 29 patients with systemic sclerosis without significant lung fibrosis and without known pulmonary arterial hypertension underwent right heart catheterization and simultaneous cardiopulmonary exercise test. A six-minute walk distance (6MWD) was determined within 48 hours. MEASUREMENTS AND MAIN RESULTS: A resting MPAP above the median (17 mm Hg) was associated with decreased 6MWD (396 +/- 71 vs. 488 +/- 76 m; P < 0.005) and peak Vo(2) (76 +/- 11% vs. 90 +/- 24%; P = 0.05). Resting pulmonary vascular resistance was inversely correlated with 6MWD (r = 0.45; P < 0.05). At 25 and 50W, MPAP above the median (23 and 28 mm Hg) was associated with decreased 6MWD (P < 0.005; P < 0.0005). At peak exercise, MPAP showed no association with 6MWD or peak Vo(2); however, cardiac index was positively (r = 0.45; P < 0.05) and pulmonary vascular resistance was negatively correlated with 6MWD (r = -0.38; P < 0.05). CONCLUSIONS: MPAP and resistance in the upper normal range at rest and moderate exercise are associated with decreased exercise capacity and may indicate early pulmonary vasculopathy in patients with systemic sclerosis. Investigations on the prognostic and therapeutic implications of such borderline findings are warranted. Clinical trial registered with http://www.clinicaltrials.gov (NCT00609349).
13
Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
Margaret M. Redfield, Steven J. Jacobsen, John C. Burnett et al. · JAMA · 2003 · 3K citations
Shoichi Miyamoto, Noritoshi Nagaya, Toru Satoh et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 1.1K citations
Romain Kessler, M Faller, Gilles Fourgaut et al. · American Journal of Respiratory and Critical Care Medicine · 1999 · 575 citations
Assessment of Survival in Patients With Primary Pulmonary Hypertension
Roland Wensel, Christian Opitz, Stefan D. Anker et al. · Circulation · 2002 · 568 citations · Full text
Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease.
E Weitzenblum, C. Hirth, A Ducoloné et al. · Thorax · 1981 · 511 citations · Full text